Here, we characterize the changes in alternative splicing induced by SF3B1 mutations in CLL patients and in an isogenic CLL MEC1 cell line bearing the most frequent SF3B1 cancer mutation (K700E). This evidence concerns the gene SF3B1 and cancer.